C

CMPS: Compass Pathways Plc

Stock

About

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Website
compasspathways.com
Year Founded
2016
Employees
166
Sector
Health Care
HQ Location
Altrincham, undefined

Current Value

$2.76

1 Year Return

$6.84
-71.25%
Created with Highcharts 11.4.822 Apr20 May17 Jun15 Jul12 Aug9 Sep7 Oct4 Nov2 Dec30 Dec27 Jan24 Feb24 Mar$2$4$6$8$10$12

Key Details

Market Cap

$194.00M

P/E Ratio

-1.23

1Y Stock Return

-71.12%

1Y Revenue Growth

-

Dividend Yield

0.00%

Price to Book

1.3

Strategies that include CMPS

Double maintains 1 strategies that include CMPS - Compass Pathways Plc

Genomic Revolution

Direct Index

High risk

$1,000

Genomic Revolution

This strategy follows the ARK Genomic Revolution ETF (ticker ARKG) which is an actively managed fund that targets companies involved in the genomics industry.

Top Sector

Health Care

Top Holdings

Bktd. Return

-9.12%

Expense Ratio

0.00%

Holdings

28

Create your own
strategy with

CMPS
Three dimensional double logo

Stock's related to CMPS

The stocks that are correlated to CMPS - Compass Pathways Plc are NNOX, RXRX, NTLA, CRSP, CACC

Name
Correlation
Market Cap
Return % (1 Year)
Div Yield %
N
NNOXNano-X Imaging Ltd.
46.93%$273.20M-57.04%0.00%
R
RXRXRecursion Pharmaceuticals, Inc.
44.84%$1.93B-44.90%0.00%
N
NTLAIntellia Therapeutics, Inc.
44.14%$713.23M-72.41%0.00%
C
CRSPCRISPR Therapeutics AG
43.79%$2.80B-49.80%0.00%
C
CACCCredit Acceptance Corp.
43.13%$5.98B-7.18%0.00%
S
SITMSiTime Corp.
41.92%$3.01B+46.02%0.00%
R
RGNXREGENXBIO, Inc.
41.75%$334.07M-65.17%0.00%
A
ABCLAbCellera Biologics, Inc.
41.26%$622.79M-52.50%0.00%
C
CRBUCaribou Biosciences, Inc.
41.13%$73.01M-82.71%0.00%
S
SPXCSPX Technologies, Inc.
40.60%$5.88B+5.18%0.00%
R
RCKTRocket Pharmaceuticals, Inc.
40.37%$592.86M-77.74%0.00%
C
COHUCohu, Inc.
40.06%$640.86M-56.61%0.00%
A
AUTLAutolus Therapeutics Plc
40.00%$401.85M-72.60%0.00%
A
ALECAlector, Inc.
39.55%$108.00M-81.08%0.00%
D
DNLIDenali Therapeutics, Inc.
39.49%$1.86B-32.65%0.00%
N
NSITInsight Enterprises, Inc.
38.99%$4.35B-26.20%0.00%
S
SLABSilicon Laboratories, Inc.
38.68%$3.22B-24.82%0.00%
A
ATXSAstria Therapeutics, Inc.
38.38%$290.64M-55.37%0.00%
A
ARWArrow Electronics, Inc.
38.36%$4.98B-24.28%0.00%
A
AOUTAmerican Outdoor Brands, Inc.
38.27%$141.80M+28.14%0.00%

ETF's related to CMPS

The ETFs that are correlated to CMPS - Compass Pathways Plc are ARKG, CPRJ, IWC, KOMP, IWO

Name
Correlation
AUM
Expense Ratio
A
ARKGARK Genomic Revolution ETF
49.45%$987.53M0.75%
C
CPRJCalamos Russell 2000 Structured Alt Protection ETF July
49.44%$48.65M0.69%
I
IWCiShares Micro Cap ETF
49.19%$809.63M0.6%
K
KOMPSPDR S&P Kensho New Economies Composite ETF
47.98%$1.98B0.2%
I
IWOiShares Russell 2000 Growth ETF
46.68%$10.93B0.24%
X
XBISPDR Biotech ETF
46.57%$5.06B0.35%
A
ARKKARK Innovation ETF
46.48%$5.16B0.75%
G
GNOMGlobal X Genomics & Biotechnology ETF
45.65%$48.48M0.5%
K
KAPRInnovator U.S. Small Cap Power Buffer ETF April
45.56%$169.45M0.79%
R
ROBTTraded Fund VI First Trust Nasdaq Artificial Intelligence and Robotics ETF
45.49%$426.00M0.65%
V
VTWOVanguard Russell 2000 Index ETF
44.84%$11.24B0.07%
I
IWMiShares Russell 2000 ETF
44.59%$63.84B0.19%
X
XSWSPDR S&P Software & Services ETF
44.49%$466.36M0.35%
Q
QQQJTraded Fund Trust II Invesco NASDAQ Next Gen 100 ETF
44.40%$600.30M0.15%
B
BUZZVanEck Social Sentiment ETF
44.10%$49.34M0.76%
P
PRNTARK 3D Printing ETF
43.94%$73.55M0.66%
I
IPORenaissance IPO ETF
43.87%$133.03M0.6%
A
ARKQARK Autonomous Technology & Robotics ETF
43.77%$844.13M0.75%
S
SCHASchwab U.S. Small Cap ETF
43.73%$16.19B0.04%
C
CWBSPDR Bloomberg Convertible Securities ETF
43.65%$3.78B0.4%

News

Finnhub

Compass Pathways PLC: * COMPASS PATHWAYS ANNOUNCES COMPLETION OF RECRUITMENT FORTHEPHASE 3 COMP005 TRIAL OF COMP360 PSILOCYBIN FORTREATMENT-RESISTANT DEPRESSION *...

SeekingAlpha

During Q4 2024, the Lazard International Strategic Equity Portfolio fell 8.7% (net), modestly lagging the MSCI EAFE Index which fell 8.1%. Click here to read more.

SeekingAlpha

During Q4 2024, the Lazard International Equity Select Portfolio fell 9.2% (net), lagging the MSCI All Country World ex-US Index which fell 7.6%. Click here to read more.

Finnhub

Highlights:52-week observational follow-up study from Phase 2b reveals single 25 mg COMP360 psilocybin dose offers longer-term antidepressant effects compared to lower doses, with average efficacy...

Finnhub

Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel...

Finnhub

Transforming Mental Health Care InvestorPresentation March2025 Compass Pathways ...

Disclaimer

Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.

Zero expense ratio
index investing

Company

Resources

Popular ETFs

ETF Comparisons

© Double Finance, 2024

Double is a registered investment adviser with the US Securities and Exchange Commission (SEC). While such registration does not imply a certain level of skill, it does require us to follow federal regulations that protect you, the investor. By law, we must provide investment advice that is in the best interest of our client. Please refer to Double's Form CRS for important additional information.

The publicly available portions of the Platform (i.e., the sections of the Platform that are available to individuals who are not party to a Client Agreement - including double.finance) are provided for educational purposes only and are not intended to provide legal, tax, or financial planning advice. To the extent that any of the content published on publicly available portions of the Platform may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Nothing on the publicly available portions of the Platform should be construed as a solicitation or offer, or recommendation, to buy or sell any security. All charts, figures, and graphs on the publicly available websites are for illustrative purposes only. Before investing, you should consider whether any investment, investment strategy, security, other asset, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You are also encouraged to consult your legal, tax, or investment professional regarding your specific situation. Registration does not imply a certain level of skill or training.

Investing involves risk. The value of your investment will fluctuate, and you may gain or lose money.

The contents of the Platform may contain forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates, and projections about the financial industry, the economy, or Global Predictions itself. Forward-looking statements are not guarantees of the underlying expected actions or future performance and future results may differ significantly from those anticipated by the forward-looking statements. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements.

¹ Data as of July 2024.

² Availability of tax loss harvesting depends on portfolio diversity.

³ As of November 8, 2024. The optional Cash Sweep program takes the cash sitting in your brokerage account and moves it to an FDIC-insured interest-earning deposit account. The current yield is 1.0%, rates subject to change at any time. The cash sweep program is made available in coordination with Apex Clearing Corporation. Please read the Important Disclosures for more information.

⁴ This analysis calculator tool is for illustrative purposes only and is not financial advice. We do not guarantee the accuracy of the results or their relevance to your particular circumstances. This calculator uses hypothetical historical data and does not take into account the effect of taxes on a taxable account. Hypothetical historical data is no guarantee of future performance and this calculator is not intended to predict actual performance. The input of different time periods, amounts, and fees will vary calculator results. Average ETF fee is based on the AUM weighted average of US ETFs as of September 2024, see more information. Note that you can purchase ETFs through Double, which may incur additional fees.

Full pricing details along with an FAQ can be found here

Data displayed in charts and graphics above are for illustrative purposes only and do not reflect actual investment results and are not a guarantee of future results.

By using double.finance, you accept our and . Double is only available to US residents.

See Double Finance Form ADV Part IIA for additional information. Double does not guarantee that the results of its advice, recommendations, or the objectives of its direct index or cash management strategies will be achieved. We make no assurance that the investment process will consistently lead to successful investing. Before you invest, you should carefully review and consider your investment objectives as well as the risks, charges, and expenses of the underlying securities. There is at least a $1,000 account minimum required to participate in Double's strategies, although some strategies may have higher minimums.

Double does not provide tax, or legal advice. Double's website, brokerage, and advisory services are not intended for persons of any jurisdiction where Double is not authorized to do business. Tax savings will vary from client to client due to many factors including market conditions, tax characteristics of securities, client-imposed investment restrictions, client tax rate or status, and changes in tax regulations.

0% Expense Ratios with TLH

We offer over 50 indexes with zero expense ratios.

Registration will take about 10 seconds